CalciMedica, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
505 COAST BOULEVARD SOUTH, LA JOLLA, CA, 92037
Mailing Address
505 COAST BOULEVARD SOUTH, LA JOLLA, CA, 92037
Phone
858-952-5500
Fiscal Year End
1231
EIN
452120079
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 10-K Annual financial report | March 3, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | March 3, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 6, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 1, 2025 | View on SEC |
| 8-K Current report of material events | November 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
Annual Reports
10-K
March 3, 2026
- Completed patient enrollment for lead candidate Auxora in acute pancreatitis, with top-line data expected in early 2026.
- Successfully raised capital through a public stock offering, strengthening the balance sheet and extending operational runway.
Material Events
8-K
Financial Distress
March 18, 2026
High Impact
- CalciMedica reported positive Phase 2b clinical trial results for its lead drug candidate, Auxora, in acute pancreatitis.
- The company has specific deadlines (September 2024) to regain Nasdaq compliance for both market capitalization and bid price.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.